Voyager Therapeutics (VYGR) EBITDA Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,003.00 |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -117,127.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117,127.00 |
| Dec 31, 2025 | -169,487.00 |
| Sep 30, 2025 | -24,941.00 |
| Jun 30, 2025 | 205,818.00 |
| Mar 31, 2025 | 277,884.00 |
| Dec 31, 2024 | -57,356.00 |
| Sep 30, 2024 | 166,155.00 |
| Jun 30, 2024 | 218,551.00 |
| Mar 31, 2024 | 27,239.00 |
| Dec 31, 2023 | 30,757.00 |
| Sep 30, 2023 | -63,804.00 |
| Jun 30, 2023 | -42,202.00 |
| Mar 31, 2023 | 21,388.00 |
| Dec 31, 2022 | 155,540.00 |
| Sep 30, 2022 | 11,697.00 |
| Jun 30, 2022 | -272,514.00 |
| Mar 31, 2022 | -273,120.00 |
| Dec 31, 2021 | 114,630.00 |
| Sep 30, 2021 | -72,504.00 |
| Jun 30, 2021 | -122,938.00 |
| Mar 31, 2021 | 176,918.00 |
| Dec 31, 2020 | -6,101.00 |
| Sep 30, 2020 | 214,835.00 |
| Jun 30, 2020 | 159,757.00 |
| Mar 31, 2020 | 98,002.00 |
| Dec 31, 2019 | 61,133.00 |
| Sep 30, 2019 | 18,071.00 |
| Jun 30, 2019 | 27,472.00 |
| Mar 31, 2019 | -37,868.00 |
| Dec 31, 2018 | -97,262.00 |
| Sep 30, 2018 | -89,309.00 |
| Jun 30, 2018 | -91,029.00 |
| Mar 31, 2018 | -153,614.00 |